Fundraising Fox

Unum Therapeutics

NASDAQ: COGT

Cambridge, US · Founded 2014 · Delaware corporation · 2 known investors

cogentbio.com ↗

Cogent Biosciences discovers, develops, and commercializes therapies targeting genetically defined diseases, with a focus on precision medicine and addressing underlying causes rather than symptoms. The company serves patients with genetic disease conditions.

BiotechDigital HealthMedical Devicesin /cogentbiosciences@CogentBio

Founders & leadership

BA
Ben AuspitzDirector
LR
Liam RatcliffeDirector
CW
Charles WilsonExecutive Officer, Director
CS
Christiana StamoulisExecutive Officer
BB
Bruce BoothDirector

Investors · 2

Atlas VentureCambridge · $500K – $1M
F-Prime Capital PartnersCambridge · $3M – $10M

Reported raises · per SEC filings

Form D private placements
▶$44.8MraisedJul 2020 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles WilsonExecutive Officer, Director
  • Arlene MorrisDirector
  • Jessica SachsExecutive Officer
  • Karen FerranteDirector
  • John L. GreenExecutive Officer
  • Matthew RosDirector
  • Chris CainDirector
  • Peter HarwinDirector
Offering amount
$44.8M
Amount sold
$44.8M
First sale
Jul 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$104.4MraisedJul 2020 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew RosDirector
  • John L. GreenExecutive Officer
  • Arlene MorrisDirector
  • Jessica SachsExecutive Officer
  • Chris CainDirector
  • Karen FerranteDirector
  • Charles WilsonExecutive Officer, Director
  • Peter HarwinDirector
Offering amount
$104.4M
Amount sold
$104.4M
First sale
Jul 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$65MraisedJun 2015 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ben AuspitzDirector
  • Liam RatcliffeDirector
  • Charles WilsonExecutive Officer, Director
  • Christiana StamoulisExecutive Officer
  • Bruce BoothDirector
Offering amount
$65M
Amount sold
$65M
First sale
Jun 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.